Adverse allergic reaction to 131I MIBG

详细信息    查看全文

• 作者：Naoya Ishibashi (1)
  Katsumi Abe (1)
  Satoru Furuhashi (1)
  Shoko Fukushima (1)
  Takashi Yoshinobu (1)
  Motoichiro Takahashi (1)
  Chiyuki Matsumoto (2)
  Kyoko Fukuda (2)
  Takayuki Kobayashi (2) (3)
  Norisuke Mochizuki (4)
  
• 关键词：131I MIBG ; Adverse reactions ; Skin eruption ; Side effect ; Radiopharmaceuticals
• 刊名：Annals of Nuclear Medicine
• 出版年：2009
• 出版时间：September 2009
• 年：2009
• 卷：23
• 期：7
• 页码：697-699
• 全文大小：117KB
• 参考文献：1. Hesslewood SR, Keeling DH. Frequency of adverse reactions to radiopharmaceuticals in Europe. Eur J Nucl Med. 1997;24:1179-2.
  2. Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996;37:185-2.
  3. Subcommittee of Safety Issue for the Radiopharmaceuticals, Medical and Pharmaceutical Committee, Japan Radioisotope Association. The twenty-second report on survey of the adverse reaction to radiopharmaceuticals (the 25th survey in 1999). Kaku Igaku. 2001;38:139-0 (in Japanese).
  4. Subcommittee of Safety Issue for the Radiopharmaceuticals, Medical and Pharmaceutical Committee, Japan Radioisotope Association. The twenty-first report on survey of the adverse reaction to radiopharmaceuticals (the 24th survey in 1998). Kaku Igaku. 2000;37:237-8 (in Japanese).
  5. Shapiro B, Copp JE, Sisson JC, Eyre PL, Wallis J, Beierwaltes WH. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases. J Nucl Med. 1985;26:576-5.
  6. Waton J, Tréchot P, Loss-Ayav C, Schmutz JL, Barbaud A. Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions. Br J Dermatol. 2009;160:786-4. CrossRef
  7. Vernassiere C, Trechot P, Commun N, Schmutz JL, Barbaud A. Low negative predictive value of skin tests in investigating delayed reactions to radio-contrast media. Contact Dermatitis. 2004;50:359-6. CrossRef
  8. Akiyama M, Nakada T, Sueki H, Fujisawa R, Iijima M. Drug eruption caused by nonionic iodinated X-ray contrast media. Acad Radiol. 1998;5(Suppl 1):S159-1. CrossRef
  9. Gao N, Qiao HL, Jia LJ, Tian X, Zhang YW. Relationships between specific serum IgE, IgG, IFN-gamma level and IFN-gamma, IFNR1 polymorphisms in patients with penicillin allergy. Eur J Clin Pharmacol. 2008;64:971-. CrossRef
  10. Nakagawa Y, Sumikawa Y, Nakamura T, Itami S, Katayama I, Aoki T. Urticarial reaction caused by ethanol. Allergol Int. 2006;55:411-. CrossRef
  11. Enokibori M, Kuge M, Mori K. Anaphylactoid reaction to maltose 5% solution during spinal anaesthesia. Can J Anaesth. 1998;45:52-. CrossRef
  12. Ay D, Aktas C, Sarikaya S, Cetin A. An unusual cause of allergy: case report of normal saline solution allergy. Am J Emerg Med. 2009;27:130.e1-. CrossRef
  13. Stern RS. Utilization of hospital and outpatient care for adverse cutaneous reactions to medications. Pharmacoepidemiol Drug Saf. 2005;14:677-4. CrossRef
  14. Jonville AP, Dutertre JP, Autret E, Barbellion M. Adverse effects of oxybutynin chloride (Ditropan). Evaluation of the official survey of regional pharmacovigilance centers. Therapie. 1992;47:389-2. (in French).
  15. Kamada MM, Twarog F, Leung DY. Multiple antibiotic sensitivity in a pediatric population. Allergy Proc. 1991;12:347-0. CrossRef
  16. Nauman J, Wolff J. Iodide prophylaxis in Poland after the Chernobyl reactor accident: benefits and risks. Am J Med. 1993;94:524-2. CrossRef
  
• 作者单位：Naoya Ishibashi (1)
  Katsumi Abe (1)
  Satoru Furuhashi (1)
  Shoko Fukushima (1)
  Takashi Yoshinobu (1)
  Motoichiro Takahashi (1)
  Chiyuki Matsumoto (2)
  Kyoko Fukuda (2)
  Takayuki Kobayashi (2) (3)
  Norisuke Mochizuki (4)
  
  1. Department of Radiology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan
  2. Department of Dermatology, Nihon University School of Medicine, 30-1 Oyaguchi Kami-cho, Itabashi-ku, Tokyo, 173-8610, Japan
  3. Pharmaceutical Department, Surugadai Nihon University Hospital, 1-8-13 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-8308, Japan
  4. Fujifilm RI Pharma, 1-17-10 Kyobashi, Chuo-ku, Tokyo, 104-0031, Japan
  

文摘

No adverse allergic reactions to iodine-131-metaiodobenzylguanidine (131I MIBG) at a diagnostic dose have been reported in the English literature. This report of a skin eruption in a 35-year-old man after an intravenous injection of 131I MIBG strongly suggests an adverse allergic reaction, and is the first to address such a side effect of 131I MIBG at a diagnostic dose. Erythematous maculopapular eruptions, some of which were contiguous, were seen in a symmetric disposition on the patient’s chest walls, elbows, neck and face 18?h after the 131I MIBG injection. Antiallergic treatment resolved the lesions completely. There were no possible causes of the exanthema other than the 131I MIBG injection. Urticaria related to the 131I MIBG injection and caused by type I allergic reaction was suspected, and these findings point to the possible risk of a hitherto unreported allergic skin reaction to 131I MIBG. We would like to draw the attention of nuclear physicians to this possible drawback of 131I MIBG.